NEUROLEPTIC MALIGNANT SYNDROME RESPONSIVE TO CARBIDOPA LEVODOPA - SUPPORT FOR A DOPAMINERGIC PATHOGENESIS

被引：23

作者：

HARRIS, M ^{[1
]}

NORA, L ^{[1
]}

TANNER, CM ^{[1
]}

机构：

[1] RUSH PRESBYTERIAN ST LUKES MED CTR,DEPT NEUROL SCI,1725 W HARRISON,CHICAGO,IL 60612

来源：

CLINICAL NEUROPHARMACOLOGY | 1987年 / 10卷 / 02期

关键词：

D O I：

10.1097/00002826-198704000-00010

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：186 / 189

页数：4

共 11 条

[1]

BIANCHINE JR, 1985, PHARMACOL BASIS THER, P473

[2] TARDIVE DYSTONIA - LATE-ONSET AND PERSISTENT DYSTONIA CAUSED BY ANTI-PSYCHOTIC DRUGS [J].

BURKE, RE ;

FAHN, S ;

JANKOVIC, J ;

MARSDEN, CD ;

LANG, AE ;

GOLLOMP, S ;

ILSON, J .

NEUROLOGY, 1982, 32 (12) :1335-1346

[3] NEUROLEPTIC MALIGNANT SYNDROME CAUSED BY DOPAMINE-DEPLETING DRUGS IN A PATIENT WITH HUNTINGTON DISEASE [J].

BURKE, RE ;

FAHN, S ;

MAYEUX, R ;

WEINBERG, H ;

LOUIS, K ;

WILLNER, JH .

NEUROLOGY, 1981, 31 (08) :1022-1026

[4]

Cox B., 1979, BODY TEMPERATURE REG, P231

[5]

FRIEDMAN JH, 1984, ANN NEUROL, V16, P126

[6]

GOULON M, 1983, NEUROLOGY, V33, P516

[7] NEUROLEPTIC MALIGNANT SYNDROME - A PATHOGENETIC ROLE FOR DOPAMINE RECEPTOR BLOCKADE [J].

HENDERSON, VW ;

WOOTEN, GF .

NEUROLOGY, 1981, 31 (02) :132-137

[8] NEUROLEPTIC MALIGNANT SYNDROME [J].

KURLAN, R ;

HAMILL, R ;

SHOULSON, I .

CLINICAL NEUROPHARMACOLOGY, 1984, 7 (02) :109-120

[9]

PFEIFFER RF, 1985, ANN NEUROL, V18, P138

[10] FATAL HYPERPYREXIA AFTER WITHDRAWAL OF LEVODOPA [J].

SECHI, G ;

TANDA, F ;

MUTANI, R .

NEUROLOGY, 1984, 34 (02) :249-251

← 1 2 →